Arkolith/Insider Trading/CHRO/Form 4

Francis Knuettel II

CEO, Pres., CFO, Treas & SectyChromocell Therapeutics Corp (CHRO) · full profile →Form 4 · filed Sep 12, 2024
Net Buying
Open-Market Buys
$11K
Open-Market Sells
$0
Net Open-Market Flow
$11K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 11, 2024Buy(P)6K$0.94$5K543K
Sep 10, 2024Buy(P)7K$0.89$6K537K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001753926-24-001570) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML